Jose Antonio Lluch-Rodrigo
Overview
Explore the profile of Jose Antonio Lluch-Rodrigo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Lacort M, Munoz-Quiles C, Mira-Iglesias A, Lopez-Labrador F, Garces-Sanchez M, Escribano-Lopez B, et al.
Pediatrics
. 2024 Oct;
155(1.
PMID: 39363387
Objectives: This study assesses the effectiveness of nirsevimab, a monoclonal antibody, in preventing medically attended respiratory syncytial virus-lower respiratory tract infections (RSV-LRTIs) in a large primary care network in Spain,...
2.
Juaneda J, Estrella-Porter P, Blanco-Calvo C, Orrico-Sanchez A, Antonio Lluch-Rodrigo J, Pastor-Villalba E
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932352
Public funding of vaccines may enhance vaccination rates, co-administration, and timeliness. The impacts of including the serogroup B meningococcus vaccine (MenB) into the national immunisation schedule on vaccination rates, co-administration...
3.
Estrella-Porter P, Blanco-Calvo C, Lameiras-Azevedo A, Juaneda J, Fernandez-Martinez S, Gomez-Pajares F, et al.
Vaccine
. 2024 Jun;
42(22):126030.
PMID: 38834430
Respiratory syncytial virus (RSV) represents a high burden of disease in children and the primary cause of hospitalization, especially in children under 1 year old. In the Valencian Community (Spain),...
4.
Lopez-Lacort M, Munoz-Quiles C, Mira-Iglesias A, Lopez-Labrador F, Mengual-Chulia B, Fernandez-Garcia C, et al.
Euro Surveill
. 2024 Feb;
29(6).
PMID: 38333937
The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023-Jan...